Skip To Main Content

Financial Assistance Options

No matter what type of health insurance you have, and even if you have none at all, there may be some potential options available to help you afford your medicine.

Quick Links


If you have insurance coverage and need help affording Esbriet, these programs may help:

Esbriet Co-pay Program

Co-pay Card Assistance

With the Esbriet Co-pay Program, eligible patients with commercial insurance could pay as little as $5 per 30-day supply of Esbriet. The rest of your co-pay or co-insurance is covered up to $25,000 in assistance per calendar year.

You may be eligible if you:

  • Are taking Esbriet for an FDA-approved use
  • Are 18 years of age or older or have a Legally Authorized Person over the age of 18 to manage the program
  • Have commercial (private or non-governmental) insurance. This includes plans available through state and federal health insurance exchanges
  • Live and receive treatment in the United States or U.S. Territories
  • Are not receiving assistance through the Legacy Patient Program or any other charitable organization for the same expenses covered by the program
  • Do not use a state or federal healthcare plan to pay for your medication. This includes, but is not limited to, Medicare, Medicaid and TRICARE

The Co-pay Program (“Program”) is valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Legacy Pharma Inc. SEZC medicine. The Program is not available to patients whose prescriptions are reimbursed under any federal, state, or government-funded insurance programs (included but not limited to Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs Programs) or where prohibited by law or by the patient's health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state or government-funded healthcare programs, the patient will no longer be eligible for the Program.

Under the Program, the patient may be required to pay a co-pay. The final amount owed by a patient may be as little as $0 for the Legacy Pharma Inc. SEZC medicine (see Program specific details available at the Program website). The total patient out-of-pocket cost is dependent on the patient’s health insurance plan. The Program assists with the cost of the Legacy Pharma Inc. SEZC medicine only. It does not assist with the cost of other medicines, procedures or office visit fees. After reaching the maximum annual Program benefit amount, the patient will be responsible for all remaining out-of-pocket expenses. The Program benefit amount cannot exceed the patient’s out-of-pocket expenses for the Legacy Pharma Inc. SEZC medicine.

All participants are responsible for reporting the receipt of all Program benefits as required by any insurer or by law. The Program is only valid in the United States and U.S. Territories, is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. No party may seek reimbursement for all or any part of the benefit received through the Program. The value of the Program is intended exclusively for the benefit of the patient. The funds made available through the Program may only be used to reduce the out-of-pocket costs for the patient enrolled in the Program. The Program is not intended for the benefit of third parties, including without limitation third party payers, pharmacy benefit managers, or their agents. If Legacy Pharma Inc. SEZC determines that a third party has implemented a program that adjusts patient cost-sharing obligations based on the availability of support under the Program and/or excludes the assistance provided under the Program from counting towards the patient’s deductible or out-of-pocket cost limitations, Legacy Pharma Inc. SEZC may impose a per fill cap on the cost-sharing assistance available under the Program. Submission of true and accurate information is a requirement for eligibility and Legacy Pharma Inc. SEZC reserves the right to disqualify patients who do not comply with Legacy Pharma Inc. SEZC Program Terms and Conditions. Legacy Pharma Inc. SEZC reserves the right to rescind, revoke or amend the Program without notice at any time.

Additional terms and conditions apply. Please visit the Co-pay Program website for the full list of Terms and Conditions.

View full TERMS AND CONDITIONS.

Apply for the Esbriet Co-pay Program

  • Commercial insurance: An insurance plan you get from a private health insurance company. This can be insurance from your job, from a plan you bought yourself or from a Health Insurance Marketplace. Medicare and Medicaid are not considered commercial insurance. 

Independent Co-pay Assistance Foundations

Independent Co-pay Assistance

An independent co-pay assistance foundation is a charitable organization providing financial assistance to patients with specific disease states, regardless of treatment. Patients who are commercially or publicly insured, including those covered by Medicare and Medicaid, can contact the foundations directly to request assistance. Eligibility requirements, all aspects of the application process, turnaround times and the type or amount of assistance available (if any) can vary by foundation. 

These foundations may be able to help. Please check their websites for up-to-date information.

These organizations are independent of Legacy Pharma Inc. SEZC and may require you to provide personal or financial information directly to the organization to enroll in their respective programs. Legacy Pharma Inc. SEZC cannot share any information you have provided to us.

Independent co-pay assistance foundations have their own rules for eligibility. We have no involvement or influence in independent foundation decision-making or eligibility criteria and do not know if a foundation will be able to help you. We can only refer you to a foundation that supports your disease state. This information is provided as a resource for you. We do not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help you.


If you have financial difficulty or do not have insurance coverage and need help affording Esbriet, this program may help:

Legacy Patient Program

Legacy Patient Program

The Legacy Patient Program gives free Esbriet to people who have been prescribed this medicine and don’t have insurance or that have financial concerns and meet certain eligibility criteria.

You may be eligible if your insurance coverage and income match one of these situations:

  • Uninsured patients with incomes under $150,000*
  • Insured patients without coverage for Esbriet with incomes under $150,000*
  • Insured patients with coverage for a Legacy Pharma Inc. SEZC medicine*:
    • With an out-of-pocket maximum set by their health insurance plan that exceeds 7.5% of their household income
    • With household size and income within certain guidelines outlined below:
      Legacy Patient Program eligibility depends on your health insurance and financial situation. You may qualify if you are in 1 of the 3 groups below:

       “I have no insurance”

       

      For a household of 1-4 people, total yearly income is under $150,000*.

       

      *For households with more than 4 people, add $25,000 to the yearly income for each additional person.

      “I have insurance, but it doesn’t cover Esbriet”

      “I have insurance that covers Esbriet, but the out-of-pocket maximum set by my health insurance plan is more than 7.5% of my yearly income”

       

      Household Size

      Yearly Income

      1 person

      Under $75,000

      2 people

      Under $100,000

      3 people

      Under $125,000

      4 people

      Under $150,000

      For households with more than 4 people, add $25,000 to the yearly income limit for each additional person.

      Not sure if you are Eligible?  Call 1-855-518-7562 to speak with a Program Specialist.

We encourage insured patients to try other financial assistance options before applying for help from the Legacy Patient Program, if possible.

Enrollment Process for the Legacy Patient Program

To get started:

  1. Complete the Program Enrollment Form, which is available in English and Spanish, below:
  2. Once you have completed the first two sections of the Patient Enrollment Form, please take the partially completed form to your prescriber who will need to fill out the rest of the form before we can help you.

Alternatively, you can enroll in the Legacy Patient Program by filling out the online forms available through the link below:

What to expect next:

  • The request will be processed within five business days upon receipt of the required form.
  • You and your provider will be contacted to discuss the application outcome and any next steps.

If you have any questions about the criteria, please contact a Program Specialist at 1-855-518-7562 (Mon.–Fri., 9AM–6PM EST).

Legacy Pharma Inc. SEZC reserves the right to modify or discontinue the program at any time and to verify the accuracy of information submitted.

Tips and links for idiopathic pulmonary fibrosis patients

Tips & Helpful Links

Find information about nutrition, exercise and resources for people living with IPF.

  • Commercial insurance: An insurance plan you get from a private health insurance company. This can be insurance from your job, from a plan you bought yourself or from a Health Insurance Marketplace. Medicare and Medicaid are not considered commercial insurance. 

  • Public insurance: A health insurance plan you get from the federal or state government. This includes Medicare, Medicaid, TRICARE and DoD/VA insurance.

  • For example, a household size of 1 with income of less than $75,000 may meet the criteria for assistance. Add $25,000 for each additional person in the household. There is no maximum number of people you may add.

Select Important Safety Information and Indication

About Esbriet

Esbriet® (pirfenidone) is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF).

It is not known if Esbriet is safe and effective in children.

Before you take Esbriet, tell your doctor if you:
  • have other medical conditions (particularly liver or kidney problems).
  • are a smoker.
  • are or plan to become pregnant or breastfeed (Esbriet has not been studied in these patients).
  • are taking any prescription or over-the-counter medicines, vitamins, or herbal supplements.
What are the possible side effects of Esbriet?

Esbriet may cause serious side effects, including:

  • liver problems. Call your doctor if you have symptoms such as yellowing of your skin or eyes, dark or brown urine, pain on the upper right side of your stomach area, bleeding or bruising more easily than normal, or increased fatigue. Your doctor will also do regular blood tests to check your liver.
  • sun sensitivity and rash. When you are outside, use sunscreen (SPF 50) and wear a hat and clothes that cover your skin to avoid getting a sunburn.
  • severe skin reactions. Call your doctor right away if you have a severe skin reaction such as skin blisters, rash, sores in the mouth, hives or any other severe skin symptoms.
  • stomach problems. Esbriet may cause stomach problems such as nausea, vomiting, diarrhea, indigestion, heartburn, and stomach pain.

Your doctor may change your dose or discontinue Esbriet if side effects do not go away.

The most common side effects of Esbriet include upper respiratory tract infections, feeling tired, headache, dizziness, loss of appetite, sinusitis, insomnia, or weight loss.

These are not all the possible side effects of Esbriet.

What should you avoid while taking Esbriet?
  • Direct exposure to sunlight, or light from sunlamps and tanning beds.
  • Other medicines that can make your skin sensitive to sunlight.
  • Smoking, which may affect how well Esbriet works.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch or to Legacy Pharma Inc. SEZC at 1-800-727-7151.

Please see full Prescribing Information, including Patient Information, for additional important safety information.